SCHEDULE: T. Rowe Price Discloses 5.6% Stake in Vicor Corp

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.6% of Vicor Corp's common stock as of March 31, 2026.

Summary

• T. Rowe Price Associates, Inc. has reported beneficial ownership of 1,888,446 shares of Vicor Corp common stock.
• This holding represents 5.6% of the total class of securities.
• The filing date for this event is March 31, 2026.
• T. Rowe Price Associates, Inc. has sole voting power over 1,769,973 shares and sole dispositive power over 1,888,446 shares.
• The filing is made under Rule 13d-1(b) and T. Rowe Price Associates, Inc. certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership by an institutional investor and does not provide new operational or financial information about Vicor Corp itself.

Positives

• T. Rowe Price Associates, Inc., a significant institutional investor, has taken a notable stake in Vicor Corp, potentially signaling confidence in the company's future prospects.
• The reporting of a 5.6% stake indicates substantial investment and potential for active engagement or influence.

Negatives

• The filing does not contain any negative financial results or operational challenges for Vicor Corp itself, as it is a disclosure of ownership by an external entity.

Risks

• While not explicitly stated as a risk for Vicor Corp, significant ownership by an institutional investor can sometimes lead to pressure for strategic changes or governance adjustments that may not align with current management's plans.
• The filing does not detail any specific risks related to Vicor Corp's business operations or financial health.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from Vicor Corp.

Management Comments

• T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.
• Ellen York, Vice President of T. Rowe Price Associates, Inc., certified that the information is true, complete, and correct.

Industry Context

StockSavvy.ai notes that institutional investor filings like this Schedule 13G are common in the technology and manufacturing sectors, particularly for companies involved in specialized components like Vicor Corp, which operates in the power module and conversion space. Significant stakes by asset managers often reflect strategic investment decisions based on market analysis and growth potential.

Stakeholder Impact

• Shareholders: The increased institutional interest may be viewed positively, potentially leading to greater liquidity or market attention for Vicor Corp shares.
• Management: Vicor Corp's management may need to consider the perspectives and potential influence of T. Rowe Price Associates, Inc. as a significant shareholder.
• Analysts: The filing provides data for analysts to incorporate into their models and assessments of Vicor Corp's ownership structure.

Next Steps

• T. Rowe Price Associates, Inc. will continue to hold or manage its beneficial ownership of Vicor Corp shares.
• Vicor Corp may engage with T. Rowe Price Associates, Inc. regarding its investment.

Key Dates

Keywords

Vicor Corp, T. Rowe Price Associates, Schedule 13G, SEC Filing, Beneficial Ownership, Common Stock, Institutional Investor, Securities Exchange Act